Dr. David Stojdl, Dr. John Bell and Dr. Brian Lichty
Canadian academic institutions and research organizations are congratulating Turnstone Biologics on a new partnership with AbbVie to develop cancer-fighting viruses (also called oncolytic viral immunotherapies).
Turnstone was founded in Ottawa based on research led by Dr. John Bell (from The Ottawa Hospital and uOttawa - middle), Dr. Brian Lichty (from McMaster University - right) and Dr. David Stojdl (from the Children’s Hospital of Eastern Ontario and uOttawa - left). The Ontario Institute for Cancer Research (OICR) and BioCanRx have also played a key role in advancing the technology.
Media inquiries
Amélie Ferron-Craig
Media Relations Officer
Cell: 613-863-7221
aferronc@uOttawa.ca